JPS606638A - α‐ケト酸の製法 - Google Patents
α‐ケト酸の製法Info
- Publication number
- JPS606638A JPS606638A JP10645483A JP10645483A JPS606638A JP S606638 A JPS606638 A JP S606638A JP 10645483 A JP10645483 A JP 10645483A JP 10645483 A JP10645483 A JP 10645483A JP S606638 A JPS606638 A JP S606638A
- Authority
- JP
- Japan
- Prior art keywords
- alkali
- dihydro
- furandione
- alpha
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000004716 alpha keto acids Chemical class 0.000 title abstract description 9
- 238000004519 manufacturing process Methods 0.000 title description 7
- 238000000034 method Methods 0.000 claims abstract description 19
- 239000003513 alkali Substances 0.000 claims abstract description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 9
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 6
- 239000011707 mineral Substances 0.000 claims abstract description 6
- 235000010755 mineral Nutrition 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 235000011121 sodium hydroxide Nutrition 0.000 claims abstract description 3
- 230000007062 hydrolysis Effects 0.000 abstract description 8
- 238000006460 hydrolysis reaction Methods 0.000 abstract description 8
- 239000002253 acid Substances 0.000 abstract description 7
- 239000002994 raw material Substances 0.000 abstract description 7
- 239000007864 aqueous solution Substances 0.000 abstract description 4
- 150000001875 compounds Chemical class 0.000 abstract description 4
- 235000008206 alpha-amino acids Nutrition 0.000 abstract description 3
- 230000003301 hydrolyzing effect Effects 0.000 abstract description 3
- 239000002904 solvent Substances 0.000 abstract description 3
- 208000037157 Azotemia Diseases 0.000 abstract description 2
- 239000003905 agrochemical Substances 0.000 abstract description 2
- 125000000217 alkyl group Chemical group 0.000 abstract description 2
- 239000007858 starting material Substances 0.000 abstract description 2
- 208000009852 uremia Diseases 0.000 abstract description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- AMIMRNSIRUDHCM-UHFFFAOYSA-N Isopropylaldehyde Chemical compound CC(C)C=O AMIMRNSIRUDHCM-UHFFFAOYSA-N 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 3
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 3
- 229940091173 hydantoin Drugs 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 150000001371 alpha-amino acids Chemical class 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000002923 oximes Chemical class 0.000 description 2
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- CKGNFKNZKFVYQG-UHFFFAOYSA-N 3-ethyl-2-oxopentanoic acid Chemical compound CCC(CC)C(=O)C(O)=O CKGNFKNZKFVYQG-UHFFFAOYSA-N 0.000 description 1
- QHKABHOOEWYVLI-UHFFFAOYSA-N 3-methyl-2-oxobutanoic acid Chemical compound CC(C)C(=O)C(O)=O QHKABHOOEWYVLI-UHFFFAOYSA-N 0.000 description 1
- 239000001388 3-methyl-2-oxobutanoic acid Substances 0.000 description 1
- JVQYSWDUAOAHFM-UHFFFAOYSA-N 3-methyl-2-oxovaleric acid Chemical compound CCC(C)C(=O)C(O)=O JVQYSWDUAOAHFM-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000003855 acyl compounds Chemical class 0.000 description 1
- -1 alcohol ethers Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000003934 aromatic aldehydes Chemical class 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 150000001469 hydantoins Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 150000004715 keto acids Chemical class 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10645483A JPS606638A (ja) | 1983-06-13 | 1983-06-13 | α‐ケト酸の製法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10645483A JPS606638A (ja) | 1983-06-13 | 1983-06-13 | α‐ケト酸の製法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS606638A true JPS606638A (ja) | 1985-01-14 |
JPS6150934B2 JPS6150934B2 (en, 2012) | 1986-11-06 |
Family
ID=14434038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10645483A Granted JPS606638A (ja) | 1983-06-13 | 1983-06-13 | α‐ケト酸の製法 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS606638A (en, 2012) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007037812A1 (en) * | 2005-09-14 | 2007-04-05 | Regents Of The University Of California | Amide forming chemical ligation |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11591936B2 (en) * | 2019-09-04 | 2023-02-28 | Saudi Arabian Oil Company | Systems and methods for proactive operation of process facilities based on historical operations data |
-
1983
- 1983-06-13 JP JP10645483A patent/JPS606638A/ja active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007037812A1 (en) * | 2005-09-14 | 2007-04-05 | Regents Of The University Of California | Amide forming chemical ligation |
Also Published As
Publication number | Publication date |
---|---|
JPS6150934B2 (en, 2012) | 1986-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4977264A (en) | Process for the production of 4,5-dichloro-6-ethylpyrimidine | |
JPS5936899B2 (ja) | α−アミノ酸アミドの製造法 | |
JP3182464B2 (ja) | 1−シアノメチル−4−カルボキシメチル−2−ケトピペラジン、それの塩類、およびそれらの製造 | |
Galat | A New Synthesis of β-Alanine | |
JPS606638A (ja) | α‐ケト酸の製法 | |
JPS6024781B2 (ja) | シス−2−ヒドロキシ−2−フエニル−r−1−シクロヘキサンカルボン酸の製造法 | |
SU619098A3 (ru) | Способ получени карбоновых кислот или их минеральных,или органических солей,или сложных эфиров | |
JPS6312048B2 (en, 2012) | ||
US4334087A (en) | Process for preparing α-ketocarboxylic acids | |
SU626691A3 (ru) | Способ получени производных оксима или их солей | |
Gaudry | Study on the synthesis of valine by the Strecker method | |
US2702816A (en) | Production of formisobutyraldol cyanohydrin | |
US3577455A (en) | Tau-butyl-alpha-methyl-gamma-nitro valerate | |
JPS63139179A (ja) | Dl−パントラクトンの光学分割法 | |
JPH0136818B2 (en, 2012) | ||
JP2691363B2 (ja) | 光学活性3,4―ジヒドロキシ酪酸誘導体の製造法 | |
JP3171483B2 (ja) | 含フッ素アミノ安息香酸誘導体 | |
JP2531501B2 (ja) | N−クロロアセチルグルタミン酸γ−低級アルキルエステルアンモニウム塩 | |
RU2673461C2 (ru) | Способ получения 4-метил-1-нитропентена-1 | |
JPS6210500B2 (en, 2012) | ||
FR2511246A1 (fr) | Nouveaux alpha-aminoderives cycliques du 1-(3',4'-methylene-dioxyphenyl)ethanol et procede de fabrication | |
CH437340A (fr) | Procédé de préparation de l'acide N-(2,3-diméthylphényl)-anthranilique | |
SU672200A1 (ru) | Способ получени производных -бутиролактонов | |
SU1680692A1 (ru) | Способ получени N-(2,3,3-триметилнорборн-2-ил)монохлорацетамида | |
JPH045026B2 (en, 2012) |